BioLife Solutions Inc
BLFS20.960USD
+0.155+0.75%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
996.62MCap. mercado
PérdidaP/E TTM
Más Datos de BioLife Solutions Inc Compañía
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Información de la empresa
Símbolo de cotizaciónBLFS
Nombre de la empresaBioLife Solutions Inc
Fecha de salida a bolsaNov 22, 1989
Director ejecutivoMr. Roderick De Greef
Número de empleados159
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 22
DirecciónSuite 310
CiudadBOTHELL
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal98021
Teléfono14254011400
Sitio Webhttps://www.biolifesolutions.com/
Símbolo de cotizaciónBLFS
Fecha de salida a bolsaNov 22, 1989
Director ejecutivoMr. Roderick De Greef
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
255.09K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
151.87K
-0.26%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
118.82K
-48.71%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
101.78K
-0.85%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
51.56K
-0.38%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
41.11K
-14.33%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
26.50K
-4.04%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
23.81K
-22.41%
Ms. Catherine (Cathy) Coste
Ms. Catherine (Cathy) Coste
Independent Director
Independent Director
5.70K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
255.09K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
151.87K
-0.26%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
118.82K
-48.71%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
101.78K
-0.85%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
51.56K
-0.38%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Product Revenue-Cell processing
21.57M
90.11%
Rental Revenue- Evo and thaw
1.58M
6.61%
Product Revenue- Evo and thaw
725.00K
3.03%
Service Revenue-Evo and thaw
60.00K
0.25%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product Revenue-Cell processing
21.57M
90.11%
Rental Revenue- Evo and thaw
1.58M
6.61%
Product Revenue- Evo and thaw
725.00K
3.03%
Service Revenue-Evo and thaw
60.00K
0.25%
Estadísticas de accionistas
Actualizado: mié., 30 de jul
Actualizado: mié., 30 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Casdin Capital, LLC
16.11%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
6.96%
The Vanguard Group, Inc.
5.84%
Fred Alger Management, LLC
3.21%
Other
57.28%
Accionistas
Accionistas
Proporción
Casdin Capital, LLC
16.11%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
6.96%
The Vanguard Group, Inc.
5.84%
Fred Alger Management, LLC
3.21%
Other
57.28%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
41.95%
Investment Advisor/Hedge Fund
33.97%
Hedge Fund
18.28%
Research Firm
2.34%
Individual Investor
2.24%
Pension Fund
1.49%
Bank and Trust
0.53%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
411
48.30M
100.98%
-4.50M
2025Q1
430
51.12M
107.57%
-1.38M
2024Q4
407
48.89M
104.05%
-2.49M
2024Q3
404
46.98M
101.82%
-6.27M
2024Q2
385
48.82M
105.97%
-2.22M
2024Q1
377
46.95M
103.67%
-5.60M
2023Q4
397
47.58M
108.04%
-4.07M
2023Q3
399
45.29M
104.13%
-2.05M
2023Q2
401
44.87M
103.50%
-2.76M
2023Q1
408
43.41M
100.74%
-4.46M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Casdin Capital, LLC
7.71M
16.2%
-1.03M
-11.77%
Jun 10, 2025
BlackRock Institutional Trust Company, N.A.
5.07M
10.66%
-141.26K
-2.71%
Mar 31, 2025
Invesco Advisers, Inc.
3.33M
7%
+274.55K
+8.99%
Mar 31, 2025
The Vanguard Group, Inc.
2.80M
5.88%
-32.12K
-1.14%
Mar 31, 2025
Fred Alger Management, LLC
1.53M
3.22%
-61.10K
-3.83%
Mar 31, 2025
State Street Global Advisors (US)
1.43M
3.01%
-35.28K
-2.40%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.35M
2.83%
+1.35M
--
Mar 31, 2025
Rockefeller Capital Management
964.26K
2.03%
+142.49K
+17.34%
Mar 31, 2025
Palisade Capital Management, LLC
947.09K
1.99%
+113.94K
+13.68%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
920.27K
1.93%
+33.27K
+3.75%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Invesco S&P SmallCap Health Care ETF
0.57%
Invesco S&P SmallCap 600 Pure Growth ETF
0.52%
First Trust Multi-Manager Small Cap Opportunities ETF
0.38%
iShares Micro-Cap ETF
0.18%
First Trust Active Factor Small Cap ETF
0.18%
SPDR S&P 600 Small Cap Growth ETF
0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.12%
iShares S&P Small-Cap 600 Growth ETF
0.11%
First Trust Small Cap Growth AlphaDEX Fund
0.1%
iShares Core S&P Small-Cap ETF
0.06%
Ver más
Invesco S&P SmallCap Health Care ETF
Proporción0.57%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción0.52%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporción0.38%
iShares Micro-Cap ETF
Proporción0.18%
First Trust Active Factor Small Cap ETF
Proporción0.18%
SPDR S&P 600 Small Cap Growth ETF
Proporción0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.12%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.11%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.1%
iShares Core S&P Small-Cap ETF
Proporción0.06%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
